Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 5Completed 5Unknown 3Terminated 3Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 697Urinary Bladder Neoplasms 256Carcinoma, Renal Cell 190Kidney Neoplasms 94Neoplasms 72Carcinoma, Transitional Cell 69Breast Neoplasms 66Lung Neoplasms 38Ovarian Neoplasms 37Melanoma 37Colorectal Neoplasms 37Stomach Neoplasms 36Non-Muscle Invasive Bladder Neoplasms 35Neoplasm Metastasis 33Pancreatic Neoplasms 31Carcinoma, Non-Small-Cell Lung 29Recurrence 26Colonic Neoplasms 25Uterine Cervical Neoplasms 20Urologic Neoplasms 20Testicular Neoplasms 20Esophageal Neoplasms 20Liver Neoplasms 18Head and Neck Neoplasms 18Disease 18Wilms Tumor 17Carcinoma, Hepatocellular 17Endometrial Neoplasms 16Sarcoma 15Prostatic Hyperplasia 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × von Hippel-Lindau Disease × Genitourinary × Clear all
NCT06391879 2024-04-30

Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma

Peking University First Hospital

Unknown
300 enrolled
Genitourinary

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT05534854 2023-08-31

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

RenJi Hospital

Unknown
500 enrolled
Genitourinary

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Kidney Neoplasms, Birt-Hogg-Dube Syndrome

NCT05843305 2023-05-06

A Study of BPI-452080 in Subjects With Solid Tumors

Betta Pharmaceuticals Co., Ltd.

Phase 1 Unknown
87 enrolled
Genitourinary

Carcinoma, Renal Cell, von Hippel-Lindau Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡